Global CRISPR-associated Nucleases Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI05242493

Publication Date:

June 7, 2024

Pages:

115

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR) systems, which form an adaptive immune system in bacteria, have been modified for genome engineering. CRISPR is a technology that can be employed to edit genes. Moreover, CRISPR technology has the potential to transform medicine and make us not only treat but also prevent many diseases.The core of CRISPR is the "Cas" proteins found in bacteria, where they help defend against viruses. CRISPR-associated (Cas) nucleases are furnishing transformative technologies for genome editing and functional genomics.
The global CRISPR-associated Nucleases market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
The 鈥淐RISPR-associated Nucleases Industry Forecast鈥� looks at past sales and reviews total world CRISPR-associated Nucleases sales in 2022, providing a comprehensive analysis by region and market sector of projected CRISPR-associated Nucleases sales for 2023 through 2029. With CRISPR-associated Nucleases sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world CRISPR-associated Nucleases industry.
This Insight Report provides a comprehensive analysis of the global CRISPR-associated Nucleases landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on CRISPR-associated Nucleases portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global CRISPR-associated Nucleases market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for CRISPR-associated Nucleases and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global CRISPR-associated Nucleases.
The Cas9 protein is the most commonly used by scientists. They recognize their substrate sequence via a Protospacer Adjacent Motif (PAM) sequence and base-pairing of the target sequence by a guide RNA (gRNA) borne by the nuclease. Upon target recognition, Cas nucleases induce a double-strand break, following which the cell's repair machinery can be co-opted to alter the genomic sequence.
This report presents a comprehensive overview, market shares, and growth opportunities of CRISPR-associated Nucleases market by product type, application, key players and key regions and countries.
Segmentation by Type:
Cas9
Cas12
Cas13
Others
Segmentation by Application:
Gene Editing Cell Line Construction
Animal Models
Bioagriculture
Gene Therapy
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Segmentation by Type:
Cas9
Cas12
Cas13
Others
Segmentation by Application:
Gene Editing Cell Line Construction
Animal Models
Bioagriculture
Gene Therapy
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
GenScript
Integrated DNA Technologies, Inc.
Aldevron
Merck
Horizon Discovery
Agilent
OriGene Technologies, Inc
New England Biolabs
NIPPON GENE CO., LTD.
Novoprotein
Applied Biological Materials Inc. (abm)

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global CRISPR-associated Nucleases Market Size 2019-2030
2.1.2 CRISPR-associated Nucleases Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for CRISPR-associated Nucleases by Country/Region, 2019, 2023 & 2030
2.2 CRISPR-associated Nucleases Segment by Type
2.2.1 Cas9
2.2.2 Cas12
2.2.3 Cas13
2.2.4 Others
2.3 CRISPR-associated Nucleases Market Size by Type
2.3.1 CRISPR-associated Nucleases Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global CRISPR-associated Nucleases Market Size Market Share by Type (2019-2024)
2.4 CRISPR-associated Nucleases Segment by Application
2.4.1 Gene Editing Cell Line Construction
2.4.2 Animal Models
2.4.3 Bioagriculture
2.4.4 Gene Therapy
2.4.5 Other
2.5 CRISPR-associated Nucleases Market Size by Application
2.5.1 CRISPR-associated Nucleases Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global CRISPR-associated Nucleases Market Size Market Share by Application (2019-2024)
3 CRISPR-associated Nucleases Market Size by Player
3.1 CRISPR-associated Nucleases Market Size Market Share by Player
3.1.1 Global CRISPR-associated Nucleases Revenue by Player (2019-2024)
3.1.2 Global CRISPR-associated Nucleases Revenue Market Share by Player (2019-2024)
3.2 Global CRISPR-associated Nucleases Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CRISPR-associated Nucleases by Region
4.1 CRISPR-associated Nucleases Market Size by Region (2019-2024)
4.2 Global CRISPR-associated Nucleases Annual Revenue by Country/Region (2019-2024)
4.3 Americas CRISPR-associated Nucleases Market Size Growth (2019-2024)
4.4 APAC CRISPR-associated Nucleases Market Size Growth (2019-2024)
4.5 Europe CRISPR-associated Nucleases Market Size Growth (2019-2024)
4.6 Middle East & Africa CRISPR-associated Nucleases Market Size Growth (2019-2024)
5 Americas
5.1 Americas CRISPR-associated Nucleases Market Size by Country (2019-2024)
5.2 Americas CRISPR-associated Nucleases Market Size by Type (2019-2024)
5.3 Americas CRISPR-associated Nucleases Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC CRISPR-associated Nucleases Market Size by Region (2019-2024)
6.2 APAC CRISPR-associated Nucleases Market Size by Type (2019-2024)
6.3 APAC CRISPR-associated Nucleases Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe CRISPR-associated Nucleases Market Size by Country (2019-2024)
7.2 Europe CRISPR-associated Nucleases Market Size by Type (2019-2024)
7.3 Europe CRISPR-associated Nucleases Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa CRISPR-associated Nucleases by Region (2019-2024)
8.2 Middle East & Africa CRISPR-associated Nucleases Market Size by Type (2019-2024)
8.3 Middle East & Africa CRISPR-associated Nucleases Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global CRISPR-associated Nucleases Market Forecast
10.1 Global CRISPR-associated Nucleases Forecast by Region (2025-2030)
10.1.1 Global CRISPR-associated Nucleases Forecast by Region (2025-2030)
10.1.2 Americas CRISPR-associated Nucleases Forecast
10.1.3 APAC CRISPR-associated Nucleases Forecast
10.1.4 Europe CRISPR-associated Nucleases Forecast
10.1.5 Middle East & Africa CRISPR-associated Nucleases Forecast
10.2 Americas CRISPR-associated Nucleases Forecast by Country (2025-2030)
10.2.1 United States Market CRISPR-associated Nucleases Forecast
10.2.2 Canada Market CRISPR-associated Nucleases Forecast
10.2.3 Mexico Market CRISPR-associated Nucleases Forecast
10.2.4 Brazil Market CRISPR-associated Nucleases Forecast
10.3 APAC CRISPR-associated Nucleases Forecast by Region (2025-2030)
10.3.1 China CRISPR-associated Nucleases Market Forecast
10.3.2 Japan Market CRISPR-associated Nucleases Forecast
10.3.3 Korea Market CRISPR-associated Nucleases Forecast
10.3.4 Southeast Asia Market CRISPR-associated Nucleases Forecast
10.3.5 India Market CRISPR-associated Nucleases Forecast
10.3.6 Australia Market CRISPR-associated Nucleases Forecast
10.4 Europe CRISPR-associated Nucleases Forecast by Country (2025-2030)
10.4.1 Germany Market CRISPR-associated Nucleases Forecast
10.4.2 France Market CRISPR-associated Nucleases Forecast
10.4.3 UK Market CRISPR-associated Nucleases Forecast
10.4.4 Italy Market CRISPR-associated Nucleases Forecast
10.4.5 Russia Market CRISPR-associated Nucleases Forecast
10.5 Middle East & Africa CRISPR-associated Nucleases Forecast by Region (2025-2030)
10.5.1 Egypt Market CRISPR-associated Nucleases Forecast
10.5.2 South Africa Market CRISPR-associated Nucleases Forecast
10.5.3 Israel Market CRISPR-associated Nucleases Forecast
10.5.4 Turkey Market CRISPR-associated Nucleases Forecast
10.6 Global CRISPR-associated Nucleases Forecast by Type (2025-2030)
10.7 Global CRISPR-associated Nucleases Forecast by Application (2025-2030)
10.7.1 GCC Countries Market CRISPR-associated Nucleases Forecast
11 Key Players Analysis
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Information
11.1.2 Thermo Fisher Scientific CRISPR-associated Nucleases Product Offered
11.1.3 Thermo Fisher Scientific CRISPR-associated Nucleases Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Thermo Fisher Scientific Main Business Overview
11.1.5 Thermo Fisher Scientific Latest Developments
11.2 GenScript
11.2.1 GenScript Company Information
11.2.2 GenScript CRISPR-associated Nucleases Product Offered
11.2.3 GenScript CRISPR-associated Nucleases Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 GenScript Main Business Overview
11.2.5 GenScript Latest Developments
11.3 Integrated DNA Technologies, Inc.
11.3.1 Integrated DNA Technologies, Inc. Company Information
11.3.2 Integrated DNA Technologies, Inc. CRISPR-associated Nucleases Product Offered
11.3.3 Integrated DNA Technologies, Inc. CRISPR-associated Nucleases Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Integrated DNA Technologies, Inc. Main Business Overview
11.3.5 Integrated DNA Technologies, Inc. Latest Developments
11.4 Aldevron
11.4.1 Aldevron Company Information
11.4.2 Aldevron CRISPR-associated Nucleases Product Offered
11.4.3 Aldevron CRISPR-associated Nucleases Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Aldevron Main Business Overview
11.4.5 Aldevron Latest Developments
11.5 Merck
11.5.1 Merck Company Information
11.5.2 Merck CRISPR-associated Nucleases Product Offered
11.5.3 Merck CRISPR-associated Nucleases Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Merck Main Business Overview
11.5.5 Merck Latest Developments
11.6 Horizon Discovery
11.6.1 Horizon Discovery Company Information
11.6.2 Horizon Discovery CRISPR-associated Nucleases Product Offered
11.6.3 Horizon Discovery CRISPR-associated Nucleases Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Horizon Discovery Main Business Overview
11.6.5 Horizon Discovery Latest Developments
11.7 Agilent
11.7.1 Agilent Company Information
11.7.2 Agilent CRISPR-associated Nucleases Product Offered
11.7.3 Agilent CRISPR-associated Nucleases Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Agilent Main Business Overview
11.7.5 Agilent Latest Developments
11.8 OriGene Technologies, Inc
11.8.1 OriGene Technologies, Inc Company Information
11.8.2 OriGene Technologies, Inc CRISPR-associated Nucleases Product Offered
11.8.3 OriGene Technologies, Inc CRISPR-associated Nucleases Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 OriGene Technologies, Inc Main Business Overview
11.8.5 OriGene Technologies, Inc Latest Developments
11.9 New England Biolabs
11.9.1 New England Biolabs Company Information
11.9.2 New England Biolabs CRISPR-associated Nucleases Product Offered
11.9.3 New England Biolabs CRISPR-associated Nucleases Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 New England Biolabs Main Business Overview
11.9.5 New England Biolabs Latest Developments
11.10 NIPPON GENE CO., LTD.
11.10.1 NIPPON GENE CO., LTD. Company Information
11.10.2 NIPPON GENE CO., LTD. CRISPR-associated Nucleases Product Offered
11.10.3 NIPPON GENE CO., LTD. CRISPR-associated Nucleases Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 NIPPON GENE CO., LTD. Main Business Overview
11.10.5 NIPPON GENE CO., LTD. Latest Developments
11.11 Novoprotein
11.11.1 Novoprotein Company Information
11.11.2 Novoprotein CRISPR-associated Nucleases Product Offered
11.11.3 Novoprotein CRISPR-associated Nucleases Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Novoprotein Main Business Overview
11.11.5 Novoprotein Latest Developments
11.12 Applied Biological Materials Inc. (abm)
11.12.1 Applied Biological Materials Inc. (abm) Company Information
11.12.2 Applied Biological Materials Inc. (abm) CRISPR-associated Nucleases Product Offered
11.12.3 Applied Biological Materials Inc. (abm) CRISPR-associated Nucleases Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Applied Biological Materials Inc. (abm) Main Business Overview
11.12.5 Applied Biological Materials Inc. (abm) Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂